title: Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
authors.forename: Benjamin P
authors.initials: BP
authors.lastname: Howden
authors.forename: Patrick G P
authors.initials: PG
authors.lastname: Charles
authors.forename: Paul D R
authors.initials: PD
authors.lastname: Johnson
authors.forename: Peter B
authors.initials: PB
authors.lastname: Ward
authors.forename: M Lindsay
authors.initials: ML
authors.lastname: Grayson
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D006801:Humans; D000069349:Linezolid; D016106:Methicillin Resistance; D023303:Oxazolidinones / Q000627:therapeutic use*; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D018461:Soft Tissue Infections / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid